Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients.
Harrison.ai leverages deep learning to solve the biggest challenges in healthcare.
Harrison.ai was founded in 2018 by Aengus Tran and Dimitry Tran. The company is based in Barangaroo, New South Wales, Australia.
Harrison.ai's mission is to continuously innovate and commercialise more efficient and affordable healthcare products and services for healthcare providers and patients.
Harrison.ai uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. The company empowers physicians and healthcare providers with customised AI-enabled tools that integrate into existing clinical workflows which ultimately lead to improved patient outcomes.
Harrison.ai has successfully developed, validated and deployed a deep learning model (‘IVY’), a patent-pending technology that has increased the clinical pregnancy success rate in IVF-treatment by over 30% (the success rate of an average embryologist selecting a successful embryo is around 65% whereas the discriminative power of Harrison.ai’s IVY is 93%).
Harrison.ai is backed by Blackbird Ventures, Horizons Ventures, Skip Capital and Ramsay Health Care. The. company raised A$29M ($19.8M) from a single Series A round on Dec 09, 2019.